Magnisense, Dassault Systèmes and Roche discuss about the future of health, during the Women’s Forum organized at Deauville, October 2015.
Magnisense moved its R&D Lab to “Le Campus”, a new facility in Lyon, in the heart of the worldwide healthcare competitiveness cluster Lyon biopole. Its head office is located in the Paris based biomedical business cluster Medicen.
Magnisense, Emergency Diag to save lives.
Magnisense designs and develops proprietary diagnostic tests for cardio-vascular diseases, based on its patented breakthrough technology (MIAtek®). After several years of research and development, the final product is about to reach the market.
This mobile device uses consumables to enable medical practitioners to diagnose cardio-vascular events, especially heart attacks, in emergency situations. In just 15 minutes, the diagnostic test measures cardiac bio-markers directly from whole blood. The technology is protected by a ring fenced portfolio of 20+ worldwide patents.